OZOBAX is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Metacel Pharmaceuticals, Llc. The primary component is Baclofen.
Product ID | 69528-301_853dcc09-d7a7-46e7-b2d6-7d440e82dae7 |
NDC | 69528-301 |
Product Type | Human Prescription Drug |
Proprietary Name | OZOBAX |
Generic Name | Baclofen |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2019-09-18 |
Marketing Category | NDA / NDA |
Application Number | NDA208193 |
Labeler Name | Metacel Pharmaceuticals, LLC |
Substance Name | BACLOFEN |
Active Ingredient Strength | 5 mg/5mL |
Pharm Classes | GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-09-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208193 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-09-18 |
Ingredient | Strength |
---|---|
BACLOFEN | 5 mg/5mL |
SPL SET ID: | 92153f69-bc9b-4bef-9a8e-751effde5c7e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
69528-301 | OZOBAX | OZOBAX |
0115-1010 | Baclofen | Baclofen |
0115-1011 | Baclofen | Baclofen |
0115-1012 | Baclofen | Baclofen |
0172-4096 | Baclofen | Baclofen |
0172-4097 | Baclofen | Baclofen |
0527-1330 | Baclofen | baclofen |
0527-1333 | Baclofen | baclofen |
0527-1337 | Baclofen | baclofen |
0603-2406 | Baclofen | Baclofen |
0603-2407 | Baclofen | Baclofen |
0615-3541 | Baclofen | Baclofen |
0615-3542 | Baclofen | Baclofen |
0615-8411 | Baclofen | Baclofen |
0615-8412 | Baclofen | Baclofen |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OZOBAX 88071622 not registered Live/Pending |
Metacel Pharmaceuticals LLC 2018-08-09 |
OZOBAX 86372981 not registered Dead/Abandoned |
Metacel Pharmaceuticals LLC 2014-08-21 |